Annual revenue:
$700.97M+$25.99M(+3.85%)Summary
- As of today (July 1, 2025), PCRX annual revenue is $700.97 million, with the most recent change of +$25.99 million (+3.85%) on December 31, 2024.
- During the last 3 years, PCRX annual revenue has risen by +$159.43 million (+29.44%).
- PCRX annual revenue is now at all-time high.
Performance
PCRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$168.92M-$18.33M(-9.79%)Summary
- As of today (July 1, 2025), PCRX quarterly revenue is $168.92 million, with the most recent change of -$18.33 million (-9.79%) on March 31, 2025.
- Over the past year, PCRX quarterly revenue has increased by +$1.81 million (+1.08%).
- PCRX quarterly revenue is now -9.79% below its all-time high of $187.25 million, reached on December 31, 2024.
Performance
PCRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$702.77M+$1.81M(+0.26%)Summary
- As of today (July 1, 2025), PCRX TTM revenue is $702.77 million, with the most recent change of +$1.81 million (+0.26%) on March 31, 2025.
- Over the past year, PCRX TTM revenue has increased by +$21.02 million (+3.08%).
- PCRX TTM revenue is now at all-time high.
Performance
PCRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | +1.1% | +3.1% |
| 3 y3 years | +29.4% | +6.9% | +21.1% |
| 5 y5 years | +66.5% | +59.8% | +72.1% |
PCRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.4% | -9.8% | +5.3% | at high | +14.4% |
| 5 y | 5-year | at high | +66.5% | -9.8% | +123.7% | at high | +72.1% |
| alltime | all time | at high | +4933.9% | -9.8% | +7609.9% | at high | >+9999.0% |
PCRX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $168.92M(-9.8%) | $702.77M(+0.3%) |
| Dec 2024 | $700.97M(+3.9%) | $187.25M(+11.1%) | $700.97M(+0.9%) |
| Sep 2024 | - | $168.57M(-5.3%) | $694.96M(+0.7%) |
| Jun 2024 | - | $178.02M(+6.5%) | $690.31M(+1.3%) |
| Mar 2024 | - | $167.12M(-7.8%) | $681.75M(+1.0%) |
| Dec 2023 | $674.98M(+1.2%) | $181.24M(+10.6%) | $674.98M(+1.4%) |
| Sep 2023 | - | $163.93M(-3.3%) | $665.69M(-0.5%) |
| Jun 2023 | - | $169.47M(+5.7%) | $669.23M(+0.0%) |
| Mar 2023 | - | $160.34M(-6.8%) | $669.17M(+0.4%) |
| Dec 2022 | $666.82M(+23.1%) | $171.96M(+2.7%) | $666.82M(+2.0%) |
| Sep 2022 | - | $167.47M(-1.1%) | $654.06M(+6.5%) |
| Jun 2022 | - | $169.41M(+7.2%) | $614.32M(+5.8%) |
| Mar 2022 | - | $157.99M(-0.8%) | $580.50M(+7.2%) |
| Dec 2021 | $541.53M(+26.0%) | $159.19M(+24.6%) | $541.53M(+5.5%) |
| Sep 2021 | - | $127.72M(-5.8%) | $513.31M(+2.0%) |
| Jun 2021 | - | $135.59M(+13.9%) | $503.07M(+13.6%) |
| Mar 2021 | - | $119.03M(-9.1%) | $442.99M(+3.1%) |
| Dec 2020 | $429.65M(+2.0%) | $130.97M(+11.5%) | $429.65M(+2.0%) |
| Sep 2020 | - | $117.48M(+55.6%) | $421.10M(+3.1%) |
| Jun 2020 | - | $75.50M(-28.6%) | $408.30M(-6.2%) |
| Mar 2020 | - | $105.68M(-13.7%) | $435.40M(+3.4%) |
| Dec 2019 | $421.03M(+24.8%) | $122.42M(+16.9%) | $421.03M(+6.9%) |
| Sep 2019 | - | $104.69M(+2.0%) | $393.72M(+5.7%) |
| Jun 2019 | - | $102.60M(+12.4%) | $372.48M(+5.2%) |
| Mar 2019 | - | $91.31M(-4.0%) | $353.98M(+5.0%) |
| Dec 2018 | $337.28M(+17.7%) | $95.11M(+14.0%) | $337.28M(+5.0%) |
| Sep 2018 | - | $83.45M(-0.8%) | $321.24M(+5.3%) |
| Jun 2018 | - | $84.11M(+12.7%) | $305.13M(+4.5%) |
| Mar 2018 | - | $74.61M(-5.7%) | $291.95M(+1.9%) |
| Dec 2017 | $286.63M | $79.08M(+17.4%) | $286.63M(+2.2%) |
| Sep 2017 | - | $67.33M(-5.1%) | $280.45M(-0.4%) |
| Jun 2017 | - | $70.93M(+2.4%) | $281.47M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $69.28M(-5.0%) | $280.18M(+1.4%) |
| Dec 2016 | $276.37M(+11.0%) | $72.90M(+6.7%) | $276.37M(+1.3%) |
| Sep 2016 | - | $68.36M(-1.8%) | $272.79M(+2.3%) |
| Jun 2016 | - | $69.64M(+6.4%) | $266.65M(+4.1%) |
| Mar 2016 | - | $65.47M(-5.5%) | $256.16M(+2.9%) |
| Dec 2015 | $249.00M(+26.0%) | $69.32M(+11.4%) | $249.00M(+3.1%) |
| Sep 2015 | - | $62.21M(+5.2%) | $241.47M(+4.4%) |
| Jun 2015 | - | $59.15M(+1.4%) | $231.30M(+5.5%) |
| Mar 2015 | - | $58.32M(-5.6%) | $219.32M(+11.0%) |
| Dec 2014 | $197.67M(+131.1%) | $61.79M(+18.7%) | $197.67M(+16.7%) |
| Sep 2014 | - | $52.05M(+10.4%) | $169.44M(+20.5%) |
| Jun 2014 | - | $47.16M(+28.6%) | $140.65M(+27.1%) |
| Mar 2014 | - | $36.66M(+9.2%) | $110.63M(+29.3%) |
| Dec 2013 | $85.55M(+118.9%) | $33.56M(+44.3%) | $85.55M(+37.0%) |
| Sep 2013 | - | $23.26M(+35.7%) | $62.44M(+31.0%) |
| Jun 2013 | - | $17.14M(+47.9%) | $47.66M(+11.2%) |
| Mar 2013 | - | $11.59M(+10.9%) | $42.87M(+9.7%) |
| Dec 2012 | $39.08M(+149.1%) | $10.45M(+23.1%) | $39.08M(+18.9%) |
| Sep 2012 | - | $8.49M(-31.3%) | $32.87M(+16.0%) |
| Jun 2012 | - | $12.34M(+58.2%) | $28.34M(+44.4%) |
| Mar 2012 | - | $7.80M(+84.4%) | $19.63M(+25.1%) |
| Dec 2011 | $15.69M(+7.7%) | $4.23M(+7.0%) | $15.69M(+15.0%) |
| Sep 2011 | - | $3.96M(+8.8%) | $13.65M(-4.1%) |
| Jun 2011 | - | $3.64M(-5.9%) | $14.22M(+4.3%) |
| Mar 2011 | - | $3.86M(+76.3%) | $13.64M(-6.3%) |
| Dec 2010 | $14.56M(-3.0%) | $2.19M(-51.7%) | $14.56M(-12.6%) |
| Sep 2010 | - | $4.53M(+48.3%) | $16.66M(+4.9%) |
| Jun 2010 | - | $3.06M(-36.1%) | $15.88M(+23.8%) |
| Mar 2010 | - | $4.78M(+11.7%) | $12.83M(+59.5%) |
| Dec 2009 | $15.01M(+7.8%) | $4.28M(+13.9%) | $8.04M(+113.9%) |
| Sep 2009 | - | $3.76M | $3.76M |
| Dec 2008 | $13.93M | - | - |
FAQ
- What is Pacira BioSciences annual revenue?
- What is the all time high annual revenue for Pacira BioSciences?
- What is Pacira BioSciences annual revenue year-on-year change?
- What is Pacira BioSciences quarterly revenue?
- What is the all time high quarterly revenue for Pacira BioSciences?
- What is Pacira BioSciences quarterly revenue year-on-year change?
- What is Pacira BioSciences TTM revenue?
- What is the all time high TTM revenue for Pacira BioSciences?
- What is Pacira BioSciences TTM revenue year-on-year change?
What is Pacira BioSciences annual revenue?
The current annual revenue of PCRX is $700.97M
What is the all time high annual revenue for Pacira BioSciences?
Pacira BioSciences all-time high annual revenue is $700.97M
What is Pacira BioSciences annual revenue year-on-year change?
Over the past year, PCRX annual revenue has changed by +$25.99M (+3.85%)
What is Pacira BioSciences quarterly revenue?
The current quarterly revenue of PCRX is $168.92M
What is the all time high quarterly revenue for Pacira BioSciences?
Pacira BioSciences all-time high quarterly revenue is $187.25M
What is Pacira BioSciences quarterly revenue year-on-year change?
Over the past year, PCRX quarterly revenue has changed by +$1.81M (+1.08%)
What is Pacira BioSciences TTM revenue?
The current TTM revenue of PCRX is $702.77M
What is the all time high TTM revenue for Pacira BioSciences?
Pacira BioSciences all-time high TTM revenue is $702.77M
What is Pacira BioSciences TTM revenue year-on-year change?
Over the past year, PCRX TTM revenue has changed by +$21.02M (+3.08%)